Search Within

Larry Norton

Formats
  1. Journal Article (409)
  2. Meeting Abstract (295)
  3. Book Section (21)
  4. Conference Paper (16)
  5. Editorial (8)
  6. Guidelines (3)
  7. Correspondence (2)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (758)
  2. Breast Medicine Service (758)
  3. Department of Medicine (758)
  4. Solid Tumor Oncology Division (758)
  5. Survivorship Research (392)
  6. GSK Faculty (222)

More Groups

People
  1. Clifford Hudis (293)
  2. Edi Brogi (114)
  3. Andrew Seidman (99)
  4. Sujata Patil (97)
  5. Mark Robson (89)
  6. Hannah Wen (82)

More People

Years
  1. 2025 (5)
  2. 2024 (19)
  3. 2023 (18)
  4. 2022 (16)
  5. 2021 (13)
  6. 2020 (26)

More Years

Publications
  1. Journal of Clinical Oncology (155)
  2. Cancer Research (79)
  3. Breast Cancer Research and Treatment (48)
  4. Clinical Cancer Research (30)
  5. Laboratory Investigation (26)
  6. Modern Pathology (24)

More Publications

Publishers
  1. American Society of Clinical Oncology (159)
  2. American Association for Cancer Research (124)
  3. Nature Publishing Group (75)
  4. Springer (61)
  5. Oxford University Press (50)
  6. Elsevier Inc. (48)

More Publishers

Results (758)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? results of immunohistochemical analysis and clinical follow-up
    Journal Article

    Wynveen, C. A.; Nehhozina, T.; Akram, M.; Hassan, M.; Norton, L.; Van Zee, K. J.; Brogi, E.
    American Journal of Surgical Pathology (2011)

    Fulltext@MSK | Save
  • MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer
    Journal Article

    Png, K. J.; Yoshida, M.; Zhang, X. H. F.; Shu, W.; Lee, H.; Rimner, A.; Chan, T. A.; Comen, E.; Andrade, V. P.; Kim, S. W.; more...
    Genes and Development (2011)

    Fulltext@MSK | Save
  • Cancer stem cells, EMT, and seeding: A rose is a rose is a rose? - The Federici et al article reviewed [Breast cancer stem cells: A new target for therapy]
    Journal Article

    Norton, L.
    Oncology (Norwalk) (2011)

    Fulltext@MSK | Save
  • Cytokinetics
    Book Section

    Norton, L.; Gilewski, T. A.
    In Hong, W. K.; Bast, R. C. Jr; Hait, W. N.; Kufe, D. W.; Pollock, R. E.; Weichselbaum, R. R.; Holland, J. F.; Frei, E. 3rd (Eds.) Holland-Frei Cancer Medicine. 8th ed (2010)

    Fulltext@MSK | Save
  • Phase II trial of saracatinib in patients (pts) with ER/PR-negative metastatic breast cancer (MBC)
    Meeting Abstract

    Traina, T. A.; Sparano, J. A.; Caravelli, J.; Patil, S.; Abbruzzi, A.; Hawke, R.; Bromberg, J.; Nonemaker, J.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Correlative biomarkers in a phase II study of dasatinib (D) and weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC)
    Meeting Abstract

    Morris, P. G.; Chang, J. C.; Abbruzzi, A.; Patil, S.; Modi, S.; Seidman, A. D.; Sklarin, N. T.; Norton, L.; Hudis, C.; Fornier, M. N.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Use of adjuvant trastuzumab with chemotherapy in women with small, node-negative, HER2-positive breast cancers
    Meeting Abstract

    McArthur, H. L.; Mahoney, K.; Morris, P. G.; Patil, S.; Jacks, L. M.; Howard, J.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (pts) with metastatic breast carcinoma (MBC): A phase I/II study
    Meeting Abstract

    Fornier, M. N.; Morris, P. G.; Abbruzzi, A.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C. T.; Dickler, M. N.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Oncology clinicians' knowledge, attitudes and practices regarding fertility preservation
    Meeting Abstract

    Goldfarb, S. B.; Dickler, M. N.; McCabe, M. S.; Thom, B.; Jia, X.; Margolies, A.; Norton, L.; Hudis, C.; Basch, E.; Kelvin, J. F.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • A novel capecitabine schedule (7 on—7 off) is feasible with lapatinib for patients with HER2-positive metastatic breast cancer refractory to trastuzumab
    Meeting Abstract

    Gajria, D.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Drullinsky, P.; D'Andrea, G.; Lake, D.; Norton, L.; Hudis, C.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save